Findings may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.
“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Children allergic to cow’s milk are smaller and weigh less, according to the first published study to characterize growth trajectories from early childhood to adolescence in children with persistent food allergies.